Nintedanib : View Uses, Dosage, Side Effects, Medi...

NINTEDONE 150, containing the active ingredient Nintedanib 150mg, is a prescription medication used primarily in the treatment of idiopathic pulmonary fibrosis (IPF), systemic sclerosis-associated interstitial lung disease (SSc-ILD), and chronic fibrosing interstitial lung diseases. It is classified as a tyrosine kinase inhibitor, designed to inhibit pathways that contribute to fibrosis and inflammation in the lungs. By targeting the processes that lead to tissue scarring, NINTEDONE 150 helps slow disease progression and improve the quality of life for patients suffering from chronic respiratory conditions.

Key Features and Ingredients of Nintedanib:

1. Active Ingredient: The primary active ingredient in NINTEDONE 150 is Nintedanib, a tyrosine kinase inhibitor that targets multiple pathways involved in the development of fibrosis. These pathways include the vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), and fibroblast growth factor (FGF) receptors, all of which play a critical role in the formation of scar tissue in the lungs. Nintedanib 150mg has been shown to effectively slow down the progression of pulmonary fibrosis, making it an essential treatment for lung diseases with fibrotic components.

2. Composition: Each NINTEDONE 150 tablet contains 150mg of Nintedanib as its active ingredient. The tablet also contains various excipients, including binders, stabilizers, and fillers, to ensure proper absorption and effectiveness. These excipients help maintain the tablet’s structural integrity and support the bioavailability of Nintedanib in the body.

3. Non-Medicinal Ingredients: In addition to Nintedanib, NINTEDONE 150 includes inactive ingredients such as lactose monohydrate, microcrystalline cellulose, and magnesium stearate, which aid in tablet formulation and stability. These ingredients are necessary for ensuring the consistent release of the active compound and maximizing its therapeutic effects.

Usage of Nintedanib:

NINTEDONE 150 is primarily prescribed for the treatment of the following conditions:

• Idiopathic Pulmonary Fibrosis (IPF): NINTEDONE 150 is used to treat IPF, a condition where lung tissue becomes progressively scarred, causing difficulty in breathing and a decline in lung function. By inhibiting the processes that lead to fibrosis, Nintedanib helps slow the progression of the disease.

• Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD): In patients with systemic sclerosis, a disease that causes hardening of the skin and organs, NINTEDONE 150 helps manage interstitial lung disease, which can lead to lung fibrosis and breathing problems.

• Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype: For other chronic interstitial lung diseases characterized by fibrosis and a progressive decline in lung function, NINTEDONE 150 offers relief by slowing the advancement of fibrosis and preserving lung health.

Benefits of Nintedanib:

• Slows Disease Progression: The primary benefit of NINTEDONE 150 is its ability to slow the progression of fibrotic lung diseases such as IPF and SSc-ILD. By targeting key pathways involved in fibrosis, Nintedanib 150mg prevents further scarring of lung tissue and helps maintain lung function over time.

• Improves Lung Function: Regular use of NINTEDONE 150 can help stabilize lung function in patients with pulmonary fibrosis, reducing symptoms such as shortness of breath, persistent cough, and fatigue.

• Enhanced Quality of Life: As NINTEDONE 150 helps slow disease progression and improve lung function, it can lead to a better quality of life for individuals with fibrotic lung diseases, allowing them to maintain more independence and perform daily tasks more comfortably.

• Reduces Respiratory Symptoms: By addressing the underlying fibrosis, NINTEDONE 150 reduces the symptoms associated with lung disease, including chronic cough, breathlessness, and fatigue, providing significant relief for patients.

• Reduces the Risk of Disease Worsening: The medication is clinically proven to reduce the likelihood of IPF and other fibrotic lung diseases worsening over time, helping patients avoid severe respiratory complications and the need for more aggressive interventions.

Conclusion:

NINTEDONE 150 (Nintedanib 150mg) is an innovative treatment for individuals suffering from idiopathic pulmonary fibrosis (IPF), systemic sclerosis-associated interstitial lung disease (SSc-ILD), and other chronic fibrosing lung conditions. By inhibiting key molecular pathways involved in fibrosis, NINTEDONE 150 helps slow disease progression, preserve lung function, and improve the overall quality of life for patients. With its broad range of benefits, including improved lung function, reduced respiratory symptoms, and the potential to slow disease worsening, NINTEDONE 150 offers a vital treatment option for those battling chronic lung diseases. As with any medication, it is essential to use NINTEDONE 150 under the supervision of a healthcare provider to ensure safe and effective treatment outcomes.Steris Healthcare Pvt Ltd, known as Sterispharma, was founded in February 2018 by a team of experienced professionals in the pharmaceutical industry. Headquartered in Navi Mumbai, the company holds certifications from WHO, GMP, and ISO, reflecting its dedication to maintaining high standards of quality and safety. Sterispharma’s mission is to provide affordable, high-quality medications across India, strictly adhering to WHO guidelines. With the convenience of an online pharmacy, customers can easily order medicines with home delivery options. The company offers a wide range of healthcare products, catering to various medical needs, from rare disease treatments to essential healthcare products. Sterispharma\'s product range includes solutions for Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology. Medicines can be conveniently ordered via Our websites—Sterisonline, Sterisindia, and Sterispharma.